Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.61 |
| ▸ | NPC1 | O15118 | 8/20 | 0.61 |
| ▸ | RAB9A | P51151 | 7/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.61 |
| ▸ | TP53 | P04637 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | HTT | P42858 | 3/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | CCR1 | P32246 | 3/20 | 0.58 |
| ▸ | CCR5 | P51681 | 3/20 | 0.58 |
| ▸ | CCR8 | P51685 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | METAP1 | P53582 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28352665 | 0.94 | KDM4E (0.55) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| Pyridine SCHEMBL27602451 | 0.93 | KDM4E (0.53) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| Urea SCHEMBL7991617 | 0.89 | KDM4E (0.50) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| Dipyridyl SCHEMBL1699769 | 0.79 | KDM4E (0.93) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| Dipyridyl SCHEMBL29601520 | 0.79 | KDM4E (0.93) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| Dipyridyl SCHEMBL143849 | 0.79 | KDM4E (0.93) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| Dipyridyl SCHEMBL1960478 | 0.79 | KDM4E (0.93) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| SCHEMBL1456153 | 0.77 | KDM4E (1.00) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| SCHEMBL1456985 | 0.77 | KDM4E (1.00) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| SCHEMBL30211369 | 0.77 | KDM4E (1.00) | KDM4ENPC1RAB9ASMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 557 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025217208-A1 | CHEMICAL MECHANICAL PLANARIZATION POLISHING FOR INTERCONNECTS DIFFUSION BARRIER MATERIALS | VERSUM MATERIALS US, LLC (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-4463230-A1 | HALF-SANDWICH TRANSITION METAL COMPLEXES AND USES THEREOF | Debreceni Egyetem (HU) | 2024-11-20 | — | — | EP | claimed |
| US-20240082433-A1 | TUMOR RESECTION PROCESS AND COMPOSITION CONTAINING IRIDIUM-CONTAINING NUCLEOSIDE | CLEVELAND STATE UNIVERSITY (US) | 2024-03-14 | — | — | US | claimed |
| CN-116425791-A | Photochromic germanium-doped cyclopentadiene condensed diaryl ethylene and preparation thereof | 香港大学 | 2023-07-14 | — | — | CN | claimed |
| WO-2023041947-A1 | HALF-SANDWICH TRANSITION METAL COMPLEXES AND USES THEREOF | DEBRECENI EGYETEM (HU) | 2023-03-23 | — | — | WO | claimed |
| CN-111085267-B | Polymer-loaded Cu/TEMPO catalyst and preparation method and application thereof | 湖北大学 | 2022-11-25 | — | — | CN | claimed |
| US-11357708-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2022-06-14 | — | — | US | claimed |
| EP-3042645-B1 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2022-04-27 | — | — | EP | claimed |
| US-20210206791-A1 | SELECTIVE METAL-MEDIATED ARYLATION OF DICHALCOGENIDES IN BIOMOLECULES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2021-07-08 | — | — | US | claimed |
| EP-1434772-A4 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2005-05-04 | — | — | EP | claimed |
| US-20040192914-A1 | Compounds and methods | SMITHKLINE BEECHAM CORPORATION | 2004-09-30 | — | — | US | claimed |
| EP-1434772-A1 | COMPOUNDS AND METHODS | SmithKline Beecham Corporation (US) | 2004-07-07 | — | — | EP | claimed |
| US-20030220371-A1 | Compounds and methods | SMITHKLINE BEECHAM CORPORATION | 2003-11-27 | — | — | US | claimed |
| EP-1274424-A4 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2003-09-17 | — | — | EP | claimed |
| WO-2003031434-A1 | COMPOUNDS AND METHODS | SMITH KLINE BEECHAM CORPORATION (US) | 2003-04-17 | — | — | WO | claimed |
| EP-1274424-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-01-15 | — | — | EP | claimed |
| WO-2001078723-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-10-25 | — | — | WO | claimed |
| EP-0150419-B1 | 2H-v-triazolyl[4,5-b]pyridines and their use | BASF Aktiengesellschaft (DE) | 1988-07-27 | — | — | EP | claimed |
| EP-0150419-A1 | 2H-v-triazolyl[4,5-b]pyridines and their use | BASF Aktiengesellschaft (DE) | 1985-08-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192914-A1 | Compounds and methods | METAP2, METAP1, DNPEP | KDM4E 1697/4885NPC1 3027/4885RAB9A 906/4885 |
| US-20240082433-A1 | TUMOR RESECTION PROCESS AND COMPOSITION CONTAINING IRIDIUM-CONTAINING NUCLEOSIDE | IMPDH1, TYMP, IMPDH2 | KDM4E 3329/4885NPC1 1823/4885RAB9A 936/4885 |
| US-20030220371-A1 | Compounds and methods | METAP2, METAP1, DNPEP | KDM4E 1351/4885NPC1 2301/4885RAB9A 1701/4885 |
| US-20210206791-A1 | SELECTIVE METAL-MEDIATED ARYLATION OF DICHALCOGENIDES IN BIOMOLECULES | SCLY, SELENOI, PTMS | KDM4E 4707/4885NPC1 4066/4885RAB9A 3701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.